Ribonucleotide reductase (RR) is an important therapeutic target for anticancer drugs. The structure of human RR features a 1: 1 complex of two homodimeric subunits, hRRM1 and hRRM2. Prokaryotically expressed and highly purified recombinant human RR subunits, hRRM1 and hRRM2, were used for holoenzyme-based [3H] CDP reduction in vitro assay. Ten new thiosemicarbazones (7–16) were synthesized and screened for their RR ...
[Rajendran, Gangadharan; Amritha, Chirakuzhi S.; Anto, Ruby John; Cheriyan, Vino T. Journal of the Serbian Chemical Society, 2010 , vol. 75, # 6 p. 749 - 761]